does it cover?
Medicareverified 2026-07-02how verdicts are made

Does Medicare cover Ozempic and Wegovy?

DOESITCOVER.COM · GENERAL VERDICT · DOESITCOVER.COM · GENERAL VERDICT ·ITDEPENDS

Medicare drug coverage for Ozempic and Wegovy depends on why the drug is prescribed — coverage is more consistent for diabetes than for weight loss, and it always depends on whether your Part D plan includes the drug on its formulary.

What flips the answer

  • Covered when

    The drug is prescribed for an FDA-approved use your Part D or Medicare Advantage drug plan's formulary covers — most commonly, Ozempic for type 2 diabetes.

  • Covered when

    You're prescribed Wegovy specifically to reduce cardiovascular risk due to existing heart disease plus overweight or obesity, and your Part D plan has added that indication to its formulary.

  • Not covered when

    The drug is prescribed solely for weight loss without a covered medical indication your plan's formulary recognizes.

  • Not covered when

    You only have Original Medicare (Parts A and B) with no Part D or Medicare Advantage drug coverage — self-administered outpatient drugs like these aren't covered at all without a drug plan.

Ozempic and Wegovy are both semaglutide, a GLP-1 medication, but they're FDA-approved for different uses — Ozempic for type 2 diabetes, Wegovy for chronic weight management (and, more recently, for reducing cardiovascular risk in people with existing heart disease and overweight or obesity). Original Medicare (Parts A and B) doesn't cover either drug directly, since these are self-administered outpatient prescription drugs — coverage runs through Medicare Part D or a Medicare Advantage plan with drug coverage.

For diabetes treatment, Ozempic is commonly included on Part D plan formularies, though the specific plan, tier, and any prior authorization requirements determine your actual cost and access.

For weight loss specifically, coverage is far less consistent. Medicare has historically excluded drugs used solely for weight loss, and that exclusion has been a long-standing barrier to GLP-1 coverage for obesity. Wegovy's newer cardiovascular-risk-reduction indication has opened the door for some Part D plans to cover it for people who meet that specific medical profile, but this varies by plan and isn't guaranteed.

The practical takeaway is that the same drug can be covered or not covered for the same person depending on which condition it's prescribed to treat and which formulary their specific Part D or Medicare Advantage plan uses.

That's the general answer. Yours is written in your actual policy.

Drop in your policy or benefits document and get the answer for your exact coverage — with the clause it comes from. Nothing is stored.

Check my policy →

Sources

  1. [1]Medicare.gov — Drug coverage (Part D)
  2. [2]Medicare.gov — Outpatient prescription drugs